Phenotypic convergence in Charcot-Marie-Tooth 2Y with novel VCP mutation
Authors:
- 1 March 2020
- journal article
- research article
- Published by Elsevier in Neuromuscular Disorders
- Vol. 30 (3) , 232-235
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Diagnostic algorithms in Charcot–Marie–Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patientsClinical Genetics, 2015
- Immunoreactivity of valosin-containing protein in sporadic amyotrophic lateral sclerosis and in a case of its novel mutantActa Neuropathologica Communications, 2014
- Charcot‐Marie‐Tooth disease: frequency of genetic subtypes in a Southern Italy populationJournal of the Peripheral Nervous System, 2014
- A novel mutation in VCP causes Charcot–Marie–Tooth Type 2 diseaseBrain, 2014
- Genetics of Charcot-Marie-Tooth (CMT) Disease within the Frame of the Human Genome Project SuccessGenes, 2014
- The VCP/p97 system at a glance: connecting cellular function to disease pathogenesisJournal of Cell Science, 2014
- Charcot–Marie–Tooth disease: frequency of genetic subtypes and guidelines for genetic testingJournal of Neurology, Neurosurgery & Psychiatry, 2012
- Charcot‐marie‐tooth disease subtypes and genetic testing strategiesAnnals of Neurology, 2011
- Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementiaAmerican Journal of Medical Genetics Part A, 2008
- Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing proteinNature Genetics, 2004